Drug Database
Back to search

France· FR:68276457

TANGANIL 500 mg, comprimé

A acetylleucin product containing acétylleucine, registered in France by PIERRE FABRE MEDICAMENT, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N07CA04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTANGANIL 500 mg, compriméATCN07CA04REGISTER NO.FR:68276457PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acétylleucineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acetylleucin is registered in 2 of 19 countries.

Countries holding a registration under ATC N07CA04 (acetylleucin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 1 of them publish a price we can compare per daily dose
Search acetylleucin products by name

Acetylleucin · ATC N07CA04

2 / 19 countries

  • Denmark
  • Franceprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTYLLEUCINE
Manufacturer
PIERRE FABRE MEDICAMENT
Country
France (FR)
ATC code
N07CA04
ATC class
Acetylleucin
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400927400209
    plaquette(s) PVC-Aluminium de 30 comprimé(s)
    EUR 2.95
  • cip13
    3400927401039
    plaquette(s) PVC-Aluminium de 60 comprimé(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N07CA04

Acetylleucin, as other registers publish it.

All acetylleucin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2ed71149-cfce-4049-85c6-9c160728b1fe
GET /v1/drugs/2ed71149-cfce-4049-85c6-9c160728b1fe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68276457",
  "date_amm": "2013-04-30",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "ACÉTYLLEUCINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about acetylleucin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console